Subscribe to Newsletter

Rob Coker Deputy Editor of The Medicine Maker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

Content by Rob Coker:

 Business & Regulation Standards & Regulation

Regulatory Flexibility in the Event of A Pandemic

| Rob Coker | 3 min read

Summarizing the updated lessons learned by the European Medicines Agency following the COVID-19 pandemic.
Manufacture Advanced Medicine

Pharma Fiction

| Rob Coker | 2 min read

A look back at The Medicine Maker archive and the influence of science fiction in the industry and science.
Manufacture Advanced Medicine

FDA or EMA Novel Drug Approvals 2024: Anagrams Edition

| Rob Coker

So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?
Business & Regulation Standards & Regulation

EFPIA Calls For Clarity Over JCA Concerns

| Rob Coker | 2 min read

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.
Manufacture Small Molecules

Small World

| Rob Coker | 5 min read

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.
Business & Regulation Digital Technologies

AI and the Copyright Question for R&D

| Rob Coker | 2 min read

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.
Manufacture Technology and Equipment

The Innovation Awards 2024

| Rob Coker | 9 min read

Welcome to our annual celebration of the top development and manufacturing technologies released over the course of the year!
Discovery & Development Advanced Medicine

The Challenges of Perfusion Perfection

| Rob Coker

How a collaboration between different organizations aims to advance perfusion for cell and gene therapies.
Business & Regulation Trends & Forecasts

Analyzing Access: Novartis is the New Leader in the 2024 Access to Medicine Index

| Rob Coker

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.
Business & Regulation Standards & Regulation

Reactions to the Nomination of Robert F Kennedy Jr. as US Health Secretary

| Stephanie Vine, Rob Coker | 5 min read

Controversial and divisive, but Kennedy’s expertise is intended for one thing: change.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker